ArticleNature communications2026

Indirect inhibition of the NLRP3-interleukin-1β axis contributes to the efficacy of JAK1 inhibitors in experimental colitis and human ulcerative colitis.

Beibei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.